As these findings potentially reflect differences in the portal pressure between the groups, we subsequently evaluated whether MFAP4 could be a prognostic marker of portal hypertension‐related hepatic decompensation in patients with cirrhosis. The gene discussed is MFAP4; the disease is portal hypertension.